Prostate Cancer

This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data from numerous sources and then select medical records that are specific to a patient’s...

October 30, 2018 — While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than caucasian men, a new analysis of genetic data from a large prospective registry and clinical data from several randomized trials indicates that...

Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel System to help reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer. The biodegradable SpaceOAR hydrogel is...

Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer, the most...

The U.S. Preventive Services Task Force (USPSTF) posted a final recommendation statement and evidence summaries on screening for prostate cancer. This final recommendation provides clinicians and their patients with important new information about the benefits and harms of prostate-specific...